Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Japanese researchers report natural DHFR inhibitors

Nov. 1, 1996

Another approval for Abelcet and further patent coverage

Nov. 1, 1996

Mentax approved for marketing

Nov. 1, 1996

Sankyo prepares pseudomonic acid derivatives

Nov. 1, 1996

Potent antifungal agent described by Morishita Roussel

Nov. 1, 1996

New antibiotic from Sankyo

Nov. 1, 1996

Cefzil approved for new indication in U.S.

Nov. 1, 1996

Expanded indications for Abelcet

Oct. 25, 1996

Seventeenth approval for Amphocil/Amphotec

Oct. 25, 1996

Key patents issued covering Applied Microbiology's lanthocins

Oct. 25, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...